Posts Tagged ‘Alphabet’
Innovation in COVID times: Otsuka and Click Therapeutics announce fully virtual clinical trial, leveraging Verily’s Project Baseline
Otsuka launches pivotal trial of digital therapeutics for depression (MedCity News): Otsuka Pharmaceutical is launching a virtual study to see if digital therapeutics can reduce depression symptoms. It’s the next step in a partnership between the Tokyo-based drugmaker and Click Therapeutics, a digital health startup that is developing programs for smoking cessation, depression and insomnia.
Read MoreAlphabet’s X shares Amber EEG system to expand the quest for mental health biomarkers
Alphabet’s X details Project Amber, a quest for a single biomarker for depression that fell short of its goal (TechCrunch): Alphabet’s X (the Google-owner’s so-called “Moonshot Factory”) published a new blog post today about Project Amber, a project it’s been working on over the past three years — the results of which it’s now making…
Read MoreVerily and LivaNova accelerate efforts to detect and treat depression
__ Heads-up about a couple fascinating developments over the last few weeks. 1) Verily’s Bold New Project Aims to Predict Depression Using Your Phone (SingularityHub): “Depression is a shifting, amorphous beast that silently haunts millions. It’s also difficult to pinpoint. Psychiatry has formulated well-tested questionnaires to diagnose depression. But these tests require patients to reach out…
Read MoreRequired: Deep partnerships between industry and academia to upgrade healthcare and biomedical research via Big Data
Join the disruptors of health science (Nature): Thomas R. Insel’s biggest lesson from his shift from NIMH director to Silicon Valley entrepreneur: academic and technology company researchers should partner up. “In early 2015, I testified with several other National Institutes of Health (NIH) directors at an annual hearing held by the US Senate. It was my…
Read MoreGoogle gets serious about brain & mental health innovation and hires NIMH Director Tom Insel
. NIH Director’s Statement Regarding Dr. Thomas Insel’s Departure: “After serving 13 years as Director for the National Institute of Mental Health (NIMH), Thomas R. Insel, M.D., will step down effective November 1, 2015…he is definitely not retiring. He is planning to join the Google Life Sciences
Read More